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ABSTRACT 
On-chip sample preparation is essential for an easy, robust and accurate operation of point-of-care (POC) diagnostic 
devices. We recently demonstrated a simple cell-counting device realised by controlled antibody release from a gelatine 
layer implemented on a microfluidic chip. However, little is known about the release kinetics from this gelatine layer 
with sub-micrometre(μm)-scale thickness. In this work, we have realised real-time and in situ monitoring of antibody 
release from sub-μm thick gelatine layers on second to minute timescale. The measured antibody release kinetics 
comply with diffusion controlled release. Release times between ~20 s and ~840 s are obtained from dry layers with the 
thicknesses between 0.25 µm and 1.5 µm. The estimated diffusion coefficient in equilibrium swelling gelatine layer is 
0.4 µm2/s. Higher drying temperatures result in a lower degree of physical crosslinking and further lead to shorter 
release time. In addition, we observe a considerably faster release from an inkjet-printed gelatine layer compared with 
the release from a cast layer prepared under comparable conditions. Moreover, the ionic strength of the medium is 
found to have a significant impact on release kinetics.   
1. INTRODUCTION 
Controlled reconstitution of anhydrous reagents integrated in microfluidic devices shows great potential in 
POC diagnostics for low-resource settings. First, the dependence of external instrumentation for precise 
reagent delivery into microfluidics is minimised. Second, the extensive bench top sample preparation is 
simplified[1]. Third, the reagent in its dry state is stable during both transport and long-term storage. The 
integration of anhydrous reagents in microfluidic devices has developed to pursue controlled release of 
reagents following rehydration for desired biochemical reactions. There are two strategies to achieve on-chip 
reagent release. One depends on the fabrication of sophisticated microfluidic chips.[2-5] The other strategy 
adopts a concept from drug delivery research by implementing a polymer matrix with embedded reagents in 
a microfluidic chip. Integrated polymer carriers, in the form of nanofibers[6] and microparticles[7], serve as 
matrices and their physiochemical properties enable controlled release of the reagents. Nevertheless, the 
preparation and integration of such polymer carriers still involve complexity. Thus, the development of a 
low-cost microfluidic device simply integrated with a polymer matrix would be a solution to realise on-chip 
reagent release for in vitro diagnostic applications. 
 
We recently demonstrated on-chip sample preparation for the enumeration of CD4+ T-lymphocytes 
using cell counting chambers containing a dry gelatine layer in which  fluorescently labelled antibodies are 
embedded.[8] In this concept, the release of antibodies following the filling of the chamber with whole blood 
is delayed by an approximately 150 nm thick gelatine layer. This delayed release is necessary to prevent 
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antibodies from being washed off by inflowing blood, thus ensure uniformity of cell staining and a high 
accuracy of the cell count.  
 
To further optimise this concept and broaden its range of applications with other reagents, a 
fundamental understanding of the release kinetics is essential. Conventional drug delivery studies generally 
focus on long-term release on the timescale of hours to days from polymer layers of tens of µm to mm 
thick.[9, 10] Microfluidics applications generally require thinner layers and shorter release times. For our 
application, gelatine layers with sub-µm-scale thickness was used to release fluorescently labelled antibodies 
within the required timescale (seconds to minutes). Few research papers have reported release kinetics from 
such thin layers or on such short timescale.[11] 
 
Therefore, we have realised real-time and in situ monitoring of release processes in microfluidic chips 
and studied the influence of various parameters on the release kinetics. Parameters are layer thickness, drying 
temperature, ionic strength of the medium and layer preparation method. In the release experiments, the 
medium passes through a fluidic chamber containing the dry gelatine layer embedding fluorescently labelled 
antibodies. This process mimics the filling of the cell counting chamber with blood. We analyse the 
fluorescence decrease from the layer during the release process using a custom-built fluorescence imaging 
setup. The layers are prepared by either casting a small volume of gelatine/antibody solution into the centre 
of the fluidic chamber or by dispensing gelatine/antibody solution using an inkjet printer. From cast layers, 
the measured kinetics fit well with diffusion controlled release. Both drying temperature and ionic strength of 
the medium strongly influence the release kinetics. Printed layers display a much faster release than cast 
layers.  
 
To the best of our knowledge, this is the first study of controlled release from sub-μm thick gelatine 
layers with a time resolution of a few seconds. Understanding the release mechanism in microfluidic chips 
would be beneficial to help tailor reagent release kinetics and may expand the applications from the delayed 
release in our cell counting chambers to on-chip reagent release triggered by external stimuli.[12] 
2. METHODS AND MATERIALS  
2.1 Fluidic chip fabrication and sample coating 
Fluidic chips were built from substrate slides (poly(methyl methacrylate) ), laminating adhesive (nominal 
thickness 25.4 µm, 3M), gelatine (type A, Bloom No. 295, Sigma),antibody (Allophycocyanin conjugated 
antiCD3, clone SK7, BD Biosciences) solutions and capping slides (Menzel). The fluidic chamber (61 mm × 
4.8 mm) was created by cutting laminating adhesive with a programmable cutting machine (Craft Robo, 
Graphtec) and attaching it to a substrate slide. Two coating procedures were applied as described below. 
After coating, a capping slide with two holes to connect tubing was attached to the adhesive, thus creating 
the chamber with a dry layer on the surface. Fig.1 shows the schematic of the fluidic chip. The assembled 
chips were stored dry at 4˚C until use. 
2.1.1  Casting 
Allophycocyanin conjugated antiCD3 (APC-αCD3) was diluted in 0.03% w/v gelatine solution to obtain a 
final concentration of 0.3 µg/ml. 3 μl of gelatine/APC-αCD3 solution was cast onto substrate slides within 
the fluidic chamber. The fluidic chamber was placed on a temperature-controlled heating stage. The solutions 
were dried at various temperatures to form circular gelatine/APC-αCD3 layers. Higher concentrations of 
gelatine solutions resulted in thicker layers. 
2.1.2  Inkjet printing 
The inkjet printing was performed using a printer (PiXDRO LP50, Roth&Rau) equipped with a piezo-
actuated single nozzle dispenser (MicroFab). The nozzle dispensed 20 pl of gelatine/APC-αCD3 drops and 
the substrate was programmably shifted during jetting to provide proper inter-drop distance which prevent 
drop merging before drying. Full coverage of the surface and variation of the layer thickness was obtained by 
successive deposition of sub-layers with spatial offsets.  
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2.2 Fluorescence imaging for monitoring of antibody release 
A custom-built fluorescence imaging setup[8] was used to measure the release kinetics. The excitation light 
from a red LED (Phlatlight CBT-40, Luminus Devices) passes a 650 nm short pass filter (Semrock) and is 
projected onto a gelatine/APC-αCD3 layer. The emitted fluorescence is collected using a close-up lens (LM-
scope) filtered with a 685/40 nm band pass filter (Semrock) and recovered by CCD camera through a 60 mm 
macro-lens (AF Micro-Nikkor, Nikon).  
 
Medium, either phosphate buffered saline (PBS) or micro-filtered deionised (DI) water, was flown 
through the fluidic chip at a rate of 1 µl/s, which is similar to the capillary flow of blood filling the cell-
counting chambers, and fluorescence images were taken every 5 s with exposure time of 1 s. Fluorescence 
intensity against layer thickness and the amount of APC-αCD3 remaining in the layer were both calibrated. 
Regions of interest (ROIs) with predetermined initial thickness were selected and analysed for all successive 
images to study the release kinetics. 
3. RESULTS AND DISCUSSION 
3.1 Characterisation of cast and printed gelatine/APC-αCD3 layers  
Fig.2 shows fluorescence images of dry gelatine/APC-αCD3 layers prepared by casting and inkjet printing. 
Gelatine and APC-αCD3 remain mixed during drying, the initial thickness of the dry layer is determined 
from the fluorescence intensity. The thickness profile of both cast and printed layers along the white line in 
Fig.2a and b is shown in Fig.2c. With respect to the cast layer, the thickness of the edge of the dry spot is 
approximately 5 times that of the interior. The presence of crystals in the dry layer is due to the salt residue 
in the gelatine/APC-αCD3 solution (Fig.2a). Crystalline region was excluded from image analysis. 
Regarding to the printed layer, thicker edge is not found in the profile. However, the overall layer is less 
smooth than the interior of the cast layer. Compared to the large volume (μl) of solution cast on a single spot, 
the printed layer is an orderd distribution of drops with small volume (pl). The roughness in the printed layer 
might be the compromised outcome of the similar thickness between the edge and the interior.  
3.2 Cast layer thickness-dependence of release  
Fig.3a shows the cumulative release of APC-αCD3 from cast gelatine layers with various initial thicknesses. 
The percentage of released antibody over total amount of antibody was calculated by comparing the APC-
αCD3 released from the layer at a given time point (Mt) to the total APC-αCD3 embedded in the layer 
(Mtotal). All the data for the first 60% of APC-αCD3 release fit well with the Higuchi model[13]:  
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The t1/2 dependency is characteristic of Fickian diffusion, suggesting the release is diffusion controlled until 
60% of APC-αCD3 is released.[14] τ is the release time and can be expressed as[15]: 
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where D is the APC-αCD3 diffusion coefficient in the gelatine layer, and L is the thickness of the gelatine 
layer. From the power law dependence Mt/Mtotal  t1/2, we can conclude that D/L² is constant during the first 
60% of the release process. The dependence of the release times on the initial thicknesses of dry gelatine 
layers, plotted in Fig.3b, clearly shows that the release time is proportional to the square of the thickness of 
dry layer. We have determined an equilibrium swelling ratio of 13.5 in PBS. The layer we prepared has 
negligible thickness compared to its diameter, therefore the swelling develops in one-dimension and swelling 
ratio is the ratio of swelling thickness over initial thickness. According to equation (2), the calculated 
diffusion coefficient of APC-αCD3 in the equilibrium swelling gelatine layer is 0.40 µm2/s,  2 orders of 
magnitude less than that in PBS[16], confirming the release is delayed by gelatine.  
3.3 Influence of drying temperature on the release from cast layers 
Gelatine/APC-αCD3 solutions were cast on the substrates at the temperatures of  27, 35 and 40˚C to create 
dry layers with average thickness of 500 nm. In Fig.4a, the layers dried at 40˚C substrate show the fastest 
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release kinetics with 36 s release time. Longer release times, 45 s and 87 s, were found for the layers dried at 
35 and 27˚C, respectively. It has been reported that the structure of gelatine layers is strongly influenced by 
the drying conditions, in particular drying temperature.[17] Gelatine layers dried at room temperature or 
lower show ordered helical structure, these layers are called ‘cold’ films. In contrast, gelatine layers dried at 
35˚C or above, called ‘hot’ films, have randomly coiled structure. Compared with amorphous ‘hot’ film, 
‘cold’ film with ordered helical structure has higher degree of physical crosslinking to resist layer expansion 
and swelling.[18] Therefore, a constrained gelatine layer dried at 27˚C leads to a slow antibody diffusion. 
3.4 Influence of ionic strength of the medium on the release from cast layers 
PBS and DI water were compared to study the influence on the release of APC-αCD3 from cast gelatine 
layers. As shown in Fig.4b, the release time in PBS is much shorter than that in DI water and almost 50% of 
APC-αCD3 seems to be trapped in the layer immersed in DI water. Both gelatine and APC-αCD3 contain 
charged functional groups. The concentrated ions in PBS couple with those charged groups and shield the 
electrostatic interactions between gelatine and antibody, making antibody molecules easily detach from the 
gelatine matrix. Without the ion competition in DI water, stronger electrostatic interactions between gelatine 
and antibody induces a longer release time and less antibody release. 
3.5 Comparison of release kinetics from cast layers and printed layers 
Inkjet printing was employed to demonstrate the feasibility of fabricating cell-counting chambers using 
production techniques. The influence of the layer preparation method on the release kinetics was studied. 
Fig.5 compares the release from cast layers and printed layers with similar thickness. It turns out that the 
release from printed layer is much faster. The composition of small-volume drops in the printed layer 
probably reduces gelatine chain entanglement and further allows for faster water penetration and faster 
swelling. Conversely, the single spot with large volume in the cast layer provides complex entanglement, 
thus supporting a tightly connected network. Further studies are needed to reveal whether this structure 
change is caused by the shear forces during the jetting process.  
4. FIGURES AND TABLES 
 
 
Figure 1: Schematic of the fluidic chip. a) side view. b) top views of cast and printed layers. 
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Figure 2: Fluorescence images a) cast layer and b) printed layer. c) The thickness profile of both cast and printed layers 
along the white lines. 
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Figure 3: a) Measured release kinetics of  APC-αCD3 from cast layers with various thicknesses fit to Mt/Mtotal=(t/τ)1/2 
(solid line). b) The release time τ is proportional to the square of the thickness of dry layer. 
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Figure 4: a) Measured release kinetics of APC-αCD3 from 500 nm thick layers dried at various temperatures fit to 
Mt/Mtotal=(t/τ)1/2 (solid line). b) Measured release kinetics of APC-αCD3 from 170 nm thick layers in DI water and PBS 
fit to Mt/Mtotal=(t/τ)1/2 (solid line). 
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Figure 5: Comparison of APC-αCD3 release from the cast layer and printed layer. Both layers are 500 nm thick. 
5.  CONCLUSIONS  
In conclusion, we have studied the release kinetics of antibody embedded in a gelatine layer with sub-μm-
scale thickness on second to minute timescale. Both cast and inkjet-printed gelatine layers were monitored by 
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real-time and in situ fluorescence imaging during the release in a flow setup. The observed first 60% of 
antibody release from cast layers is proportional to t1/2, as expected for diffusion controlled release. Also, the 
dependence of the release time on the thickness of the dry layer indicates a diffusion controlled process. 
Drying temperature and medium ionic strength have significant impact on release kinetics. Much faster 
release is observed from printed layers. A deeper understanding of this release mechanism would help to 
address the challenge of reagent and sample mixing in microfluidic chips. 
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